Mechanism of Action
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Clinical Trials (5)
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood
Loss of Exclusivity
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 7713938 | Apr 15, 2027 | SubstanceProduct | — |
| 7713938*PED | Oct 15, 2027 | — | |
| 7579449 | Aug 1, 2028 | Substance | — |
| 7579449*PED | Feb 1, 2029 | — | |
| 8551957 | Oct 14, 2029 | U-1651 |